Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500108092Phase 4Not yet recruiting
Phase 4, randomised trial of lidocaine in pharyngitis, Nasal pain and epistaxis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of moderate or severe throat pain within 3 hours after the operation. Planned start Aug 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500108092.